CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Gen-Probe Incorporated is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Gen-Probe Incorporated
35 Crosby Drive
Phone: (781) 999-7300p:781 999-7300 Bedford, MA  01730  United States Ticker: GPROGPRO

This company was Merged or Acquired on 8/1/2012.
This company ceased filing statements with the SEC on 8/13/2012.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Gen-Probe Incorporated (Gen-Probe) is engaged in the development, manufacture and marketing molecular diagnostic products and services, which are used primarily to diagnose human diseases, screen donated human blood, and ensures transplant compatibility. The Company’s molecular diagnostic products are designed to detect diseases and engaged in the categories of the in vitro diagnostics (IVD) industry. The Company markets a range of nucleic acid tests (NATs), to detect infectious micro-organisms, including those causing sexually transmitted diseases (STDs), tuberculosis, strep throat, and other infections. The Company’s clinical diagnostics products include its APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Its molecular tests can be performed on its TIGRIS instrument, an automated NAT system for diagnostics and blood screening.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
-Yes-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/201212/31/2011YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, President, Chief Executive Officer Carl W.Hull 53 12/31/2011 2/14/2007
Chief Financial Officer, Senior Vice President - Finance HermRosenman 63 5/1/2007 6/1/2001
Executive Vice President, Chief Scientist Daniel L.Kacian 64 1/1/2002
12 additional Officers and Directors records available in full report.

Business Names
Business Name
Bioanalysis Limited
Food DNA Services Limited
Gen-Probe Australia Pty Ltd
28 additional Business Names available in full report.

General Information
Number of Employees: 1,391 (As of 12/31/2011)
Outstanding Shares: 45,386,659 (As of 4/25/2012)
Shareholders: 5,881
Stock Exchange: NASD
Federal Tax Id: 330044608
Email Address: customerservice@gen-probe.com


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, May 22, 2019